XML 39 R28.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Earnings Per Share (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2024
Notes Tables |
Schedule of the calculation of basic and diluted earnings per share | The following table reflects the calculation of basic and diluted earnings per share (in thousands, except per share amounts):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Quarter Ended | ​ | Nine Months Ended
​ | ​ | March 31, | ​ | March 31,
​ |  | 2024 |  | 2023 | ​ | 2024 |  | 2023
Earnings per share – basic: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net earnings, including noncontrolling interest | ​ | $ | 49,059 |  | $ | 70,218 | ​ | $ | 127,517 |  | $ | 209,958
Less net earnings (loss) attributable to noncontrolling interest | ​ | ​ | — |  | ​ | — | ​ | ​ | — |  | ​ | 179
Net earnings attributable to Bio-Techne | ​ | $ | 49,059 | ​ | $ | 70,218 | ​ | $ | 127,517 | ​ | $ | 209,779
Income allocated to participating securities | ​ |  | (5) | ​ |  | (16) | ​ |  | (24) | ​ |  | (52)
Income available to common shareholders | ​ | $ | 49,054 | ​ | $ | 70,202 | ​ | $ | 127,493 | ​ | $ | 209,727
Weighted-average shares outstanding – basic | ​ |  | 157,309 | ​ |  | 157,311 | ​ |  | 157,655 | ​ |  | 157,071
Earnings per share – basic | ​ | $ | 0.31 | ​ | $ | 0.45 | ​ | $ | 0.81 | ​ | $ | 1.34
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Earnings per share – diluted: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Net earnings, including noncontrolling interest | ​ | $ | 49,059 | ​ | $ | 70,218 | ​ | $ | 127,517 | ​ | $ | 209,958
Less net earnings (loss) attributable to noncontrolling interest | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 179
Net earnings attributable to Bio-Techne | ​ | $ | 49,059 | ​ | $ | 70,218 | ​ | $ | 127,517 | ​ | $ | 209,779
Income allocated to participating securities | ​ |  | (5) | ​ |  | (16) | ​ |  | (24) | ​ |  | (52)
Income available to common shareholders | ​ | $ | 49,054 | ​ | $ | 70,202 | ​ | $ | 127,493 | ​ | $ | 209,727
Weighted-average shares outstanding – basic | ​ |  | 157,309 | ​ |  | 157,311 | ​ |  | 157,655 | ​ |  | 157,071
Dilutive effect of stock options and restricted stock units | ​ |  | 3,187 | ​ |  | 4,304 | ​ |  | 3,162 | ​ |  | 4,697
Weighted-average common shares outstanding – diluted | ​ |  | 160,496 | ​ |  | 161,615 | ​ |  | 160,817 | ​ |  | 161,768
Earnings per share – diluted | ​ | $ | 0.31 | ​ | $ | 0.43 | ​ | $ | 0.79 | ​ | $ | 1.30

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration